0 Table of Contents |
1 Home |
2 Capability Statement |
3 Downloads |
4 Example Image |
5 Example NASH |
6 Example NSCLC |
7 Image Profiles |
8 Models |
9 NASH Profiles |
10 NSCLC Profiles |
11 Searchparameters |
12 Security |
13 Terminologies |
14 Visual Image |
15 Visual NASH |
16 Visual NSCLC |
17 Artifacts Summary |
17.1 Image CapabilityStatement |
17.2 NASH CapabilityStatement |
17.3 NSCLC CapabilityStatement |
17.4 DiagnosticReport-category |
17.5 DiagnosticReport-code |
17.6 DiagnosticReport-date |
17.7 DiagnosticReport-id |
17.8 DiagnosticReport-status |
17.9 DiagnosticReport-subject |
17.10 ImagingStudy-dicom-class |
17.11 ImagingStudy-endpoint |
17.12 ImagingStudy-id |
17.13 ImagingStudy-identifier |
17.14 ImagingStudy-instance |
17.15 ImagingStudy-modality |
17.16 ImagingStudy-patient |
17.17 ImagingStudy-series |
17.18 ImagingStudy-started |
17.19 ImagingStudy-status |
17.20 ImagingStudy-subject |
17.21 Observation-category |
17.22 Observation-code |
17.23 Observation-date |
17.24 Observation-id |
17.25 Observation-performer |
17.26 Observation-status |
17.27 Observation-subject |
17.28 醫學影像報告邏輯模型 |
17.29 非小細胞癌邏輯模型 |
17.30 非酒精性脂肪肝邏輯模型 |
17.31 Condition |
17.32 DiagnosticReport Image |
17.33 DiagnosticReport LC |
17.34 Encounter |
17.35 Endpoint |
17.36 Image Bundle |
17.37 Image Composition |
17.38 ImagingStudy |
17.39 Media |
17.40 NASH DiagnosticReport |
17.41 Observation Imaging result |
17.42 Observation LC Ancillary studies |
17.43 Observation LC Angiolymphatic invasion |
17.44 Observation LC Cell type |
17.45 Observation LC Gross Finding |
17.46 Observation LC Histologic pattern |
17.47 Observation LC Histologic type |
17.48 Observation LC Lymph nodes |
17.49 Observation LC Metastasis |
17.50 Observation LC Non-tumorous parenchma |
17.51 Observation LC Pathological staging |
17.52 Observation LC Perineural invasion |
17.53 Observation LC Pleural invasion |
17.54 Observation LC Resection margin |
17.55 Observation LC Size of invasive focus |
17.56 Observation LC Spread Through Air Spaces (STAS) |
17.57 Observation LC T category |
17.58 Observation LC Total tumor size |
17.59 Observation LC Treatment effect |
17.60 Observation LC Tumor grading |
17.61 Observation LC Tumor necrosis |
17.62 Observation NASH Ballooning |
17.63 Observation NASH Brunt scoring system |
17.64 Observation NASH CRN scoring system |
17.65 Observation NASH Fibrosis |
17.66 Observation NASH Fibrosis |
17.67 Observation NASH Fibrosis stage |
17.68 Observation NASH Intralobular degeneration/necrosis |
17.69 Observation NASH Knodell score system |
17.70 Observation NASH Lobular inflammation |
17.71 Observation NASH Metavir fibrosis score |
17.72 Observation NASH Necroinflammatory Grading |
17.73 Observation NASH Periportal/bridging necrosis |
17.74 Observation NASH Portal inflammation |
17.75 Observation NASH Sample size |
17.76 Observation NASH Steatosis |
17.77 Organization |
17.78 Patient |
17.79 Practitioner |
17.80 基於 TW CORE IG 的 Specimen |
17.81 Acquisition Modality |
17.82 ICD-O-3 Morphology |
17.83 ImagingStudy Category Type |
17.84 ImagingStudy Identifier Type |
17.85 LOINC Radiology |
17.86 NASH-Ballooning |
17.87 NASH-Fibrosis |
17.88 NASH-Fibrosis Staging |
17.89 NASH-Fibrosis-Stage |
17.90 NASH-Intralobular Degeneration/Necrosis |
17.91 NASH-Knodell score system |
17.92 NASH-Lobular Inflammation |
17.93 NASH-Metavir Fibrosis Score |
17.94 NASH-NASH-Periportal/Bridging Necrosis |
17.95 NASH-Necroinflammatory Grading |
17.96 NASH-Portal-Inflammation |
17.97 NASH-Stage |
17.98 NASH-Steatosis |
17.99 NASH_variables |
17.100 NSCLC-Histologic-pattern |
17.101 NSCLC-Invasion |
17.102 NSCLC-MicroscopicFinding |
17.103 NSCLC-Pleural invasion |
17.104 NSCLC-pM |
17.105 NSCLC-pN |
17.106 NSCLC-pT |
17.107 NSCLC-pTNM |
17.108 NSCLC-WHO GRADE |
17.109 臺灣健保署2023年中文版ICD-10-PCS-B-Imaging值集 |
17.110 臺灣健保署2023年中文版ICD-10-PCS-C-Nuclear Medicine 值集 |
17.111 臺灣健保署2023年中文版ICD-10-PCS-D-Radiation Therapy值集 |
17.112 Acquisition Modality |
17.113 ICD-O-3 Morphology |
17.114 ImagingStudy Identifier Type |
17.115 NASH-Ballooning |
17.116 NASH-Fibrosis |
17.117 NASH-Fibrosis Staging |
17.118 NASH-Fibrosis-Stage |
17.119 NASH-Intralobular Degeneration/Necrosis |
17.120 NASH-Knodell score system |
17.121 NASH-Lobular Inflammation |
17.122 NASH-Necroinflammatory Grading |
17.123 NASH-Periportal/Bridging Necrosis |
17.124 NASH-Portal-Inflammation |
17.125 NASH-Stage |
17.126 NASH-Steatosis |
17.127 NASH_variables |
17.128 NSCLC-Histologic-pattern |
17.129 NSCLC-MicroscopicFinding |
17.130 NSCLC-Pleural invasion |
17.131 NSCLC-pM |
17.132 NSCLC-pN |
17.133 NSCLC-pT |
17.134 NSCLC-pTNM |
17.135 NSCLC-WHO GRADE |
17.136 臺灣2023年中文版ICD-10-PCS-B-Imaging |
17.137 臺灣2023年中文版ICD-10-PCS-C-NuclearMedicine |
17.138 臺灣2023年中文版ICD-10-PCS-D-RadiationTherapy |
17.139 Ancillarystudies |
17.140 Angiolymphaticinvasion |
17.141 Celltype |
17.142 DiagnosticReportLC |
17.143 GrossFinding |
17.144 Histologicpattern |
17.145 Histologictype |
17.146 ImageBundle |
17.147 ImageDiagnosticReport |
17.148 ImagingStudyBase |
17.149 Lymphnodes |
17.150 MediaBase |
17.151 Metastasis |
17.152 MitwEndpoint |
17.153 NASHBallooning |
17.154 NASHBruntScoringSystem |
17.155 NASHCRNScoringSystem |
17.156 NASHDiagnosticReport |
17.157 NASHFibrosis |
17.158 NASHFibrosisStage |
17.159 NASHFibrosisStaging |
17.160 NASHGrossFinding |
17.161 NASHIntralobularDegenerationNecrosis |
17.162 NASHKnodellScoreSystem |
17.163 NASHLobularInflammation |
17.164 NASHMetavirFibrosisScore |
17.165 NASHNecroinflammatoryGrading |
17.166 NASHPeriportalBridgingNecrosis |
17.167 NASHPortalInflammation |
17.168 NASHSteatosis |
17.169 Nontumorousparenchyma |
17.170 ObservationImagingResult |
17.171 Pathologicalstaging |
17.172 Perineuralinvasion |
17.173 Pleuralinvasion |
17.174 Resectionmargin |
17.175 Sizeofinvasivefocus |
17.176 SpreadThroughAirSpaces |
17.177 Tcategory |
17.178 Totaltumorsize |
17.179 Treatmenteffect |
17.180 Tumorgrading |
17.181 Tumornecrosis |
17.182 TWCoreCondition |
17.183 TWCoreEncounter |
17.184 TWCoreOrganization |
17.185 TWCorePatient |
17.186 TWCorePractitioner |
17.187 TWCoreSpecimen |
17.188 醫療影像及報告 |